Cisani Francesca, Roggeri Alessandra, Olivero Guendalina, Garrone Beatrice, Tongiani Serena, Di Giorgio Francesco Paolo, Pittaluga Anna
Department of Pharmacy, DIFAR, Pharmacology and Toxicology Section and Center of Excellence for Biomedical Research, University of Genoa, Genoa, Italy.
Angelini RR&D (Research, Regulatory & Development), Angelini Pharma S.p.A., Rome, Italy.
Front Pharmacol. 2020 Jul 17;11:1108. doi: 10.3389/fphar.2020.01108. eCollection 2020.
We investigated whether chronic sciatic ligation modifies the glutamate release in spinal cord nerve endings (synaptosomes) as well as the expression and the function of presynaptic release-regulating mGlu2/3 autoreceptors and 5-HT heteroreceptors in these particles. Synaptosomes were from the spinal cord of animals suffering from the sciatic ligation that developed on day 6 post-surgery a significant decrease of the force inducing paw-withdrawal in the lesioned paw. The exocytosis of glutamate (quantified as release of preloaded [H]D-aspartate, [H]D-Asp) elicited by a mild depolarizing stimulus (15 mM KCl) was significantly increased in synaptosomes from injured rats when compared to controls (uninjured rats). The mGlu2/3 agonist LY379268 (1000 pM) significantly inhibited the 15 mM KCl-evoked [H]D-Asp overflow from control synaptosomes, but not in terminals isolated from injured animals. Differently, a low concentration (10 nM) of (±) DOI, unable to modify the 15 mM KCl-evoked [H]D-Asp overflow in control spinal cord synaptosomes, significantly reduced the glutamate exocytosis in nerve endings isolated from the injured rats. Acute oral trazodone (TZD, 0.3 mg/kg on day 7 post-surgery) efficiently recovered glutamate exocytosis as well as the efficiency of LY379268 in inhibiting this event in spinal cord synaptosomes from injured animals. The sciatic ligation significantly reduced the expression of mGlu2/3, but not of 5-HT, receptor proteins in spinal cord synaptosomal lysates. Acute TZD recovered this parameter. Our results support the use of 5-HT antagonists for restoring altered spinal cord glutamate plasticity in rats suffering from sciatic ligation.
我们研究了慢性坐骨神经结扎是否会改变脊髓神经末梢(突触体)中的谷氨酸释放,以及这些颗粒中突触前释放调节型代谢型谷氨酸受体2/3(mGlu2/3)自身受体和5-羟色胺(5-HT)异源受体的表达与功能。突触体取自接受坐骨神经结扎的动物的脊髓,这些动物在术后第6天,患侧爪诱发爪缩回的力量显著下降。与对照组(未受伤大鼠)相比,轻度去极化刺激(15 mM氯化钾)引发的谷氨酸胞吐作用(以预加载的[H]D-天冬氨酸,即[H]D-Asp的释放量来量化)在受伤大鼠的突触体中显著增加。mGlu2/3激动剂LY379268(1000 pM)能显著抑制对照组突触体中15 mM氯化钾诱发的[H]D-Asp溢出,但对从受伤动物分离出的神经末梢则无此作用。不同的是,低浓度(即10 nM)的(±)DOI,在对照组脊髓突触体中无法改变15 mM氯化钾诱发的[H]D-Asp溢出,但却能显著降低从受伤大鼠分离出的神经末梢中的谷氨酸胞吐作用。急性口服曲唑酮(TZD,术后第7天剂量为0.3 mg/kg)能有效恢复受伤动物脊髓突触体中的谷氨酸胞吐作用,以及LY379268抑制该过程的效率。坐骨神经结扎显著降低了脊髓突触体裂解物中mGlu2/3受体蛋白的表达,但对5-HT受体蛋白的表达无影响。急性给予TZD可使该参数恢复正常。我们的研究结果支持使用5-HT拮抗剂来恢复坐骨神经结扎大鼠脊髓中改变的谷氨酸可塑性。